Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Development of a Patient-Reported Outcome Measure for Hypereosinophilic Syndrome.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 25, 2025
Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: February 03, 2023
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size.
Journal: The Laryngoscope
Published: August 10, 2018
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Journal: Blood
Published: February 22, 2018
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
Journal: Journal of leukocyte biology
Published: January 23, 2018
Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.
Journal: Frontiers in medicine
Published: May 07, 2017
Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis.
Journal: PloS one
Published: June 03, 2016
Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1-dependent pathway.
Journal: The Journal of allergy and clinical immunology
Published: December 31, 2015
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.
Journal: The World Allergy Organization journal
Published: November 03, 2015
Detection of Intracellular Cytokines by Flow Cytometry.
Journal: Current protocols in immunology
Published: August 04, 2015
IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3.
Journal: The Journal of allergy and clinical immunology
Published: July 24, 2015
Last Updated: 09/26/2026